Journal
NUCLEIC ACIDS RESEARCH
Volume 51, Issue D1, Pages D1263-D1275Publisher
OXFORD UNIV PRESS
DOI: 10.1093/nar/gkac812
Keywords
-
Categories
Ask authors/readers for more resources
Drug resistance has become a major global healthcare issue. This study introduces a comprehensive database called 'DRESIS' that provides information on all types of drug resistance mechanisms and covers a wide range of diseases. The database includes extensively validated resistance data, making it a valuable resource for future drug discovery and clinical treatment optimization.
Widespread drug resistance has become the key issue in global healthcare. Extensive efforts have been made to reveal not only diverse diseases experiencing drug resistance, but also the six distinct types of molecular mechanisms underlying this resistance. A database that describes a comprehensive list of diseases with drug resistance (not just cancers/infections) and all types of resistance mechanisms is now urgently needed. However, no such database has been available to date. In this study, a comprehensive database describing drug resistance information named 'DRESIS' was therefore developed. It was introduced to (i) systematically provide, for the first time, all existing types of molecular mechanisms underlying drug resistance, (ii) extensively cover the widest range of diseases among all existing databases and (iii) explicitly describe the clinically/experimentally verified resistance data for the largest number of drugs. Since drug resistance has become an ever-increasing clinical issue, DRESIS is expected to have great implications for future new drug discovery and clinical treatment optimization. It is now publicly accessible without any login requirement at: https://idrblab.org/dresis/ [GRAPHICS] .
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available